Pharmaniaga Berhad (KLSE:PHARMA)

Pharmaniaga Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	375	512	555	714	969	1,309
Market Cap Growth	-7.79%	-7.79%	-22.28%	-26.35%	-25.92%	143.16%
Enterprise Value	1,440	1,709	1,690	1,800	1,749	2,023
Last Close Price	0.26	0.35	0.39	0.55	0.67	0.87
PE Ratio	2.84	3.88	-	-	5.63	47.60
Forward PE	7.65	10.60	24.06	11.24	11.53	20.20
PS Ratio	0.10	0.14	0.16	0.21	0.20	0.48
PB Ratio	-2.57	-3.51	-2.02	-2.05	2.06	3.69
P/TBV Ratio	-	-	-	-	3.95	9.63
P/FCF Ratio	32.56	44.46	-	-	-	-
P/OCF Ratio	8.78	11.99	11.82	-	-	-
PEG Ratio	-	-	-	-	0.85	0.61
EV/Sales Ratio	0.38	0.45	0.50	0.52	0.36	0.74
EV/EBITDA Ratio	4.84	5.75	229.97	32.36	5.22	21.42
EV/EBIT Ratio	5.52	6.55	-	64.27	5.69	29.93
EV/FCF Ratio	125.11	148.48	-	-	-	-
Debt / Equity Ratio	-8.17	-8.17	-4.35	-3.35	1.82	1.89
Debt / EBITDA Ratio	4.01	4.01	65.02	18.83	2.53	6.83
Debt / FCF Ratio	103.57	103.57	-	-	-	-
Asset Turnover	1.92	1.92	1.81	1.70	2.51	1.72
Inventory Turnover	5.39	5.39	4.60	3.09	4.52	4.03
Quick Ratio	0.30	0.30	0.24	0.19	0.22	0.27
Current Ratio	0.62	0.62	0.55	0.58	1.11	0.78
Return on Equity (ROE)	-	-	-	-1027.82%	41.73%	7.38%
Return on Assets (ROA)	8.35%	8.35%	-0.68%	0.85%	10.01%	2.66%
Return on Capital (ROIC)	16.61%	16.61%	-1.47%	1.63%	16.32%	4.33%
Return on Capital Employed (ROCE)	665.10%	665.10%	-	-	38.90%	17.50%
Earnings Yield	35.18%	25.77%	-14.45%	-88.23%	17.76%	2.10%
FCF Yield	3.07%	2.25%	-0.67%	-28.24%	-9.74%	-2.67%
Dividend Yield	-	-	-	3.49%	13.78%	2.54%
Payout Ratio	-	-	-	-	34.24%	95.10%
Buyback Yield / Dilution	-5.38%	-5.38%	-4.40%	-0.05%	-0.04%	-0.33%
Total Shareholder Return	-5.38%	-5.38%	-4.40%	3.44%	13.74%	2.21%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.